Bridget Leyland

  • Citations Per Year
Learn More
BACKGROUND Serologic assays that identify herpes simplex type 2 (HSV-2) type-specific antibodies have been commercially available for more than a decade. Greater acceptance of these tests is hindered by uncertainty regarding their performance in real-world clinical settings. OBJECTIVES The primary objective was to compare the test characteristics of the(More)
  • 1